The FDA inspection found a lack of assurance of sterility and identified GMP violations that could impact product quality and sterility. As a result, the affected product is being recalled.
法规动态2026年8月24日•1 分钟阅读
FDA Identifies GMP Violations Affecting Sterility Assurance
An FDA inspection uncovered GMP violations that may compromise product sterility and quality, prompting a recall.
由 PharmaCountry 团队整理 · 来源： FDA.gov
评分
(0)
(0)
(0)
(0)
(0)
留下您的评分